GlassScriptPhysician profile
Evelyn Yu
NPI 1184635476
$4,241.63
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $612 · 2020: $688 · 2021: $658 · 2022: $847 · 2023: $1,133 · 2024: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,384 · Entertainment: $32.68 · Education: $19.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,384.07 |
| Entertainment | $32.68 |
| Education | $19.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,061.46 | 2019-2024 | Breztri, Farxiga, Fasenra |
| Janssen Pharmaceuticals, INC | $648.23 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $356.08 | 2020-2023 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $339.00 | 2022-2024 | |
| Novo Nordisk INC | $223.65 | 2019-2023 | Wegovy |
| Mylan Specialty L.P. | $142.49 | 2019-2020 | |
| Amgen INC. | $118.60 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $81.94 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $76.16 | 2019 | |
| Glaxosmithkline, LLC. | $36.84 | 2022-2023 | Shingrix, Bexsero |
| Optos, INC. | $32.68 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Astellas Pharma US INC | $30.59 | 2021 | |
| Daiichi Sankyo INC. | $28.80 | 2020-2021 | |
| Kiniksa Pharmaceuticals, LTD. | $19.30 | 2023 | Arcalyst |
| Pfizer INC. | $18.65 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $13.72 | 2019 | |
| Masimo Corporation | $13.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evelyn Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.